Department of Pharmacology, Tokushima University School of
Dentistry, Tokushima, Japan
The perfusion of rat small intestinal lumen with epinephrine (0.1 mM)
resulted in a significant increase in the amount of benzylpenicillin
(BP) transported from the mucosal to the serosal side. In this study,
the perfusion of the lumen with phenylephrine, clonidine, dobutamine,
or salbutamol had no effect on BP transport. However, the combinations
of phenylephrine and isoproterenol, clonidine and isoproterenol, and
phenylephrine and salbutamol increased the BP transport to a similar
extent as that observed with epinephrine alone. Tolazolin or
propranolol inhibited the epinephrine-induced increase in BP transport.
An increase in the intracellular concentration of cAMP in conjunction
with specific activation of either
1- or
2-adrenoceptors induced an increase in BP transport
similar to that observed in response to epinephrine alone.
Staurosporine or
N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide abolished the epinephrine-induced increase in BP transport. Peptides or
either zwitterionic or anionic cephalosporins also blocked the effect
of epinephrine on BP transport. The extent of BP uptake into brush
border or basolateral membrane vesicles prepared from epinephrine-perfused intestinal loops was markedly greater than that
into vesicles prepared from control loops. The perfusion of intestinal
lumen with carbonyl cyanide p-trifluoromethoxy
phenylhydrazone, amiloride, or ouabain inhibited epinephrine-induced BP
transport. These results indicate that the interaction of epinephrine
with both
2-adrenoceptors and either
1-
or
2-adrenoceptors markedly stimulates the BP transport,
an effect likely mediated by the enhancement of the function in the
brush border membrane of intestinal epithelial cells coupled with the
generation of an H+ gradient.
 |
Introduction |
The
intestinal (PepT1) and renal (PepT2) peptide transporters have been
cloned from mammals (Fei et al., 1994
; Liang et al., 1995
; Saito
et al., 1995
). These transporters are expressed predominantly in the
brush border membrane (BBM) of intestinal and renal epithelial cells
(Ogihara et al., 1996
) and are responsible for the uptake of small
peptides and zwitterionic cephalosporins (Ganapathy et al., 1995
).
PepT1 is also capable of transporting anionic
-lactam antibiotics,
including penicillins and cephalosporins (Doring et al., 1996
). These
transport systems are energy-dependent and driven by a transmembrane
H+ gradient (Okano et al., 1986
; Tsuji et al.,
1987
).
The organic anion transporter Npt1 also contributes to the transport of
-lactam antibiotics, including both zwitterionic and anionic
derivatives, in rat hepatocytes (Yabuuchi et al., 1998
), choroid plexus
(Suzuki et al., 1987
), and renal BBM (Tamai et al., 1988
). This
transporter mediates Cl
-dependent, but
Na+- and pH-independent transport of anionic
drugs (Jacquemin et al., 1994
). The observation that the
Cl
conductance induced by expression of the
Na+/Pi cotransporter NaPi-1 in Xenopus
oocytes was inhibited by benzylpenicillin (BP) and probenecid (Busch et
al., 1996
) also suggests that NaPi-1 mediates the transport of BP in
addition to Na+- and pH-dependent Pi transport.
NaPi-1 shares 65% amino acid sequence identity with rat and human Npt1
(Yabuuchi et al., 1998
).
The activities of many types of transporters are regulated by the
interaction of neurotransmitters with their respective receptors. For
example, epinephrine increases the activity of the
Na+/H+ antiporter by acting
at
2-adrenoceptors in glioma cells (Isom et
al., 1987
) and increases that of the
Na+/K+/2Cl
cotransporter through
-adrenoceptor activation in tracheal
epithelial cells (Haas et al., 1995
). In contrast, epinephrine inhibits
the Na+/K+/2Cl
cotransporter via
-adrenoceptor activation in lymphocytes (Feldman, 1992
). This neurotransmitter also increases the amount of the Na+/glucose cotransporter (SGLT1) in the BBM of
intestinal epithelial cells by interacting with
-adrenoceptors in
the basolateral membrane (BLM) and thereby stimulates glucose
absorption from rat small intestine (Ishikawa et al., 1997
). Moreover,
acetylcholine acting at M3 muscarinic receptors
induces the translocation of aquaporin-5 water channel to the cell
membrane in rat parotid gland (Ishikawa et al., 1998
).
However, it remains to be determined whether transporters responsible
for the absorption of
-lactam antibiotics are functionally coupled
to neurotransmitter receptors in rat small intestine. BP, one of the
anionic penicillins, is transported by the H+
gradient-dependent, carrier-mediated transport system shared by
zwitterionic and anionic
-lactam antibiotics and peptides (Doring et
al., 1996
; Poschet et al., 1996
; Wenzel et al., 1996
). With the use of
BP as a model substrate, we investigated whether the absorption of this
compound by rat small intestine is regulated by neurotransmitters. We
found that epinephrine markedly increases the absorption of BP from rat
small intestine by interacting with both
2-adrenoceptors and either
1- or
2-adrenoceptors, and we further characterized
the mechanism of this effect.
 |
Experimental Procedures |
Materials.
[3H]BP (718 GBq/mmol) was
obtained from New England Nuclear (Wilmington, DE). EDTA and
epinephrine were obtained from Dojindo Laboratories (Kumamoto, Japan)
and Mann Research Laboratories (New York, NY), respectively. Carbonyl
cyanide p-trifluoromethoxy phenylhydrazone (FCCP), BP,
l-phenylephrine hydrochloride, clonidine hydrochloride,
dobutamine hydrochloride, prazosin hydrochloride, yohimbine
hydrochloride, and tolazoline hydrochloride were purchased from Sigma
Chemical Co. (St. Louis, MO). Acetylcholine hydrochloride and
dl-isoproterenol hydrochloride were purchased from Aldrich Chemical Co. (Milwaukee, WI). Salbutamol (albuterol hemisulfate) and
N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide
dihydrochloride (H-8) were obtained from Research Biochemicals Inc.
(Natick, MA) and Seikagaku Co. (Tokyo, Japan), respectively.
Animals and Diet.
Male Wistar rats (10 weeks old) were used
for the experiments. They were provided with a standard laboratory diet
(MF; Oriental Yeast, Tokyo, Japan) and water ad libitum and maintained
in a temperature-controlled environment (22 ± 2°C) with a 12-h
light/dark cycle (lights on at 6:00 AM) for at least 2 weeks before the
experiments. All procedures were approved by the Animal Care Committee
of Tokushima University.
Perfusion of Intestinal Loops and Measurement of Transmural BP
Transport.
Rats were sacrificed by a blow to the head, and the
abdomen was opened by a midline incision. A 15-cm loop of jejunum,
starting at a point 10 cm below the ligament of Treitz, was cut from
the small intestine and then cleaned by flushing with Ringer's
solution (118 mM NaCl, 4.7 mM KCl, 1.2 mM
KH2PO4, 1.25 mM
CaCl2, 1.2 mM MgCl2, and
24.9 mM NaHCO3 gassed with a mixture of 95%
O2, 5% CO2, pH 7.4) as
described previously (Ishikawa et al., 1997
). The loop was cannulated
and connected to a perfusion apparatus with a peristaltic pump.
Perfusion of the lumen of the loop with Ringer's solution containing 1 mM BP and a trace amount of
[phenyl-4(n)-3H]BP
([3H]BP) was initiated immediately at a rate of
1 ml/min and was continued for 15 min at 37°C. The perfusate was then
changed to fresh solution with or without the addition of various agents.
The serosal side of the loop was bathed in an aerated organ bath of a
Magnus apparatus filled with 50 ml of Ringer's solution at 37°C.
After 15 min, the solution bathing the serosal side of the loop was
also removed and replaced with fresh Ringer's solution. To prevent an
overshoot phenomenon from affecting our transport data, we perfused
intestinal lumen with BP for 15 min. The determination of BP transport
activity was initiated by the addition of various agents to the
perfusate and was achieved by measurement of the amount of
radioactivity in the serosal medium with the use of a liquid
scintillation spectrometer (model LSC 5100; Aloka, Tokyo, Japan). The
amount of BP transported was calculated from the specific radioactivity
of [3H]BP in the perfusate and expressed as
nanomoles of BP per gram of tissue (wet weight) per 30 min.
Preparation of BBM and BLM Vesicles.
After perfusion of the
loop of jejunum, mucosa was scraped from the tissue with a glass slide
and homogenized in 10 volumes of buffer 1 [5 mM HEPES-HCl (pH 7.4), 50 mM mannitol, and 0.25 mM MgCl2] with a glass
homogenizer and Teflon pestle. BBM and BLM vesicles were then prepared
as described by Longbottom and Heyningen (1989)
. In brief, the
homogenate was filtered through a nylon bolting cloth (150 mesh), and
the filtrate was centrifuged at 300g for 10 min at 4°C.
The resulting supernatant was then centrifuged consecutively at
2000g for 10 min, 9750g for 10 min, and
35,000g for 30 min, with removal of the pellet after each step. The final pellet was suspended in buffer 1, after which 1 M
MgCl2 was added to a final concentration of 10 mM
and the suspension was maintained on ice for 30 min. The suspension was then centrifuged at 3000g for 15 min to separate BLMs. After
washing the resultant pellet with 1 mM EDTA (pH 7.4) by centrifugation to remove any excess MgCl2, the final pellet was
suspended in buffer 2 [20 mM HEPES-Tris (pH 7.4), 300 mM mannitol, 0.1 mM MgSO4, and 0.02% NaN3]
and used as the source of BLM vesicles (fraction 1). The
3000g supernatant was again centrifuged at
35,000g for 30 min to separate BBMs. The resultant pellet
was washed with 1 mM EDTA (pH 7.4), and the final pellet was suspended
in buffer 3 [10 mM HEPES-Tris (pH 7.4), 100 mM mannitol, and 100 mM
KCl] (Okano et al., 1986
) and used as the source of BBM vesicles
(fraction 2).
The activities of alkaline phosphatase, as a marker of BBMs, and of
Na+,K+-ATPase, a marker of
BLMs, were determined in the two membrane fractions according to the
methods of Mircheff and Wright (1976)
and Murer et al. (1976)
,
respectively. The specific activities of alkaline phosphatase were
0.067 ± 0.005 and 1.002 ± 0.080 µmol/min/mg protein in
fractions 1 and 2, respectively, whereas those of
Na+,K+-ATPase were
0.338 ± 0.035 and 0.024 ± 0.005 µmol/min/mg protein, respectively. These data indicated that fractions 1 and 2 were indeed
enriched in BLMs and BBMs, respectively.
Uptake of [3H]BP into BBM and BLM Vesicles.
The amount of BP taken up into BBM or BLM vesicles was quantified with
the use of [3H]BP. BBM vesicles (0.25 mg
protein) suspended in buffer 3 or BLM vesicles suspended in buffer 2 were incubated in a final volume of 1 ml of the same buffer containing
various concentrations of BP and a trace amount of
[3H]BP. The Tris-HCl (pH 7.4) of buffer 2 or 3 was replaced by Mes-Tris (pH 6.0) to create a pH gradient across
the vesicle membranes. After incubation of vesicles for various times
at 25°C as described by Okano et al. (1986)
, 5 ml of ice-cold buffer
2 or 3 was added, and the mixture was passed through a filter (GF/F;
Whatman, Maidstone, England). The filter was washed three times with 5 ml of ice-cold buffer 2 or 3, and the remaining filter-associated
radioactivity was determined by scintillation spectroscopy after
placing the filter in a vial containing 10 ml of scintillation fluid.
In separate experiments, nonspecific adsorption was estimated by the
addition of ice-cold buffer 2 or 3 containing various concentrations of BP and a trace amount of [3H]BP to BBM vesicle
suspension or BLM vesicle suspension, respectively. The amount of BP
incorporated into vesicles was expressed in nanomoles per milligram of protein.
Other Methods.
cAMP and protein were measured according to
the method described by Longbottom and Heyningen (1989)
.
Statistical Analysis.
All data are given as mean ± S.E. The significance of differences between mean values was determined
by the unpaired Student's t test or by one-way ANOVA
followed by Fisher's t test. A value of P < .05 was considered statistically significant.
 |
Results |
Effects of Epinephrine and Acetylcholine on BP Transport in Rat
Small Intestine.
The addition of epinephrine at concentrations of
1 µM to 1 mM to the solution perfusing the mucosal side of rat small
intestinal lumen markedly increased the amount of
[3H]BP transported to the serosal side (Fig.
1). This effect of epinephrine was
dose-dependent and reached a maximum (4-fold increase) at a
concentration of 0.1 mM, with an EC50 value of
4.22 ± 0.86 µM. The amount of BP transported in the presence of
0.1 mM epinephrine increased as the concentration of BP was increased
from 0 to 1.2 mM (Fig. 2), reaching a
maximum at 1.0 mM. Kinetic analysis according to the Michaelis-Menten
equation of BP transport in the presence and absence of 0.1 mM
epinephrine yielded apparent Km values
of 0.28 ± 0.01 and 0.21 ± 0.02 mM and
Vmax values of 323 ± 27 and 88.6 ± 5.6 nmol/g wet wt./30 min, respectively. Acetylcholine (1.0 mM) did not have a stimulatory effect on the BP transport in rat
small intestine (Table 1).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of epinephrine concentration on the transport
of BP in rat small intestine. Rat small intestinal lumen that had been
equilibrated with Ringer's solution containing 1 mM BP and a trace
amount of [3H]BP were perfused for 30 min with the same
solution containing the indicated concentrations of epinephrine. The
amount of BP transported from the mucosal to the serosal side of the
loops was then determined as described in Experimental
Procedures. Data are mean ± S.E. for four to eight loops.
*P < .05, **P < .01, ***P < .001 versus value for the absence of
epinephrine.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Concentration-response relation for BP transport in
rat small intestine perfused with or without epinephrine. a, rat small
intestinal lumen that had been equilibrated with Ringer's solution
containing the indicated concentrations of BP and a trace amount of
[3H]BP was perfused for 30 min with the same solution in
the presence or absence of 0.1 mM epinephrine. The amount of BP
transported from the mucosal to the serosal side of the loops was then
determined. Data are mean ± S.E. for four to eight loops. b,
Eadie-Hofstee plot (V versus V/S), where
V is the velocity of BP transport (nmol/g wet wt./30
min). and S is BP concentration (mM).
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1
Effects of adrenergic and cholinergic agonists on BP transport in rat
small intestine
After equilibration with Ringer's solution containing 1 mM BP and a
trace amount of [3H]BP, rat small intestinal lumen was
perfused for 30 min with the same solution in the presence of the
indicated agonists. The amount of BP in the serosal solution was then
determined as described in the text. Data are mean ±S.E. for four to
eight loops.
|
|
As shown in Table 1, the apparent extent of the mucosal-to-serosal
transport of BP was 229.5 ± 18.8 and 56.3 ± 4.8 nmol/g wet
wt./30 min in loops perfused with or without epinephrine, respectively.
The addition of 0.1 mM epinephrine to the mucosal solution induced only
a 1.3-fold increase in the amount of the serosal-to-mucosal transport
of [3H]BP, showing that epinephrine had
little effect on BP transport in this direction; 3.91 ± 0.18 and
5.08 ± 0.20 nmol/g wet wt./30 min were transported from the
serosal to the mucosal side in control and epinephrine-stimulated
intestinal loops, respectively. On the basis of these results, the net
transport of BP from the mucosal to the serosal side was estimated to
be 60.2 ± 2.3 and 234.6 ± 8.9 nmol/g wet wt./30 min in
control and epinephrine-stimulated loops, respectively. Furthermore,
although the addition of 0.1 mM epinephrine to the perfusate of the
mucosal side of normal loops resulted in a 4-fold increase in the
extent of the mucosal to serosal transport of BP, the same
concentration of epinephrine added in the serosal solution of such
loops induced a 3.5-fold increase in BP transport in the same direction
(control, 45.6 ± 4.8 nmol/g wet wt./30 min; epinephrine,
157.7 ± 10.2 nmol/g wet wt./30 min). In addition, Saito et al.
(1996)
reported that permeation of
-lactam was highly secretory
oriented; perfusion rates from the serosal to the mucosal side were 2- to 3-fold greater than those from the mucosal to the serosal side.
Thus, the addition of epinephrine to either the perfusate of the
mucosal side or the solution bathing the serosal side stimulated BP
transport from the mucosal to the serosal side. The accumulation of BP
within enterocytes did not differ significantly between loops perfused with 0.1 mM epinephrine and those perfused without agent (control, 4.67 ± 0.40 pmol/mg protein/30 min; epinephrine, 4.66 ± 0.16 pmol/mg protein/30 min). Finally, our data showed that in the
15-cm intestinal loop stimulated by epinephrine, 2.0% of the total
amount of BP added into the mucosal perfusate was transported from the
mucosal to the serosal side for 30 min, and simultaneously 2.2% of the amount of BP that was detected in the serosal solution was secreted to
the mucosal side, demonstrating that 1.96 and 0.04% of the total
amount of BP were identified as the rates of absorption and secretion,
respectively. On the other hand, in the nontreated intestinal loop,
0.5% of the total amount of BP added into the mucosal perfusate was
transported from the mucosal to the serosal side for 30 min, and
simultaneously 1.7% of the total amount of BP that was detected in the
serosal solution was secreted to the mucosal side, demonstrating that
0.49 and 0.01% of the total amount of BP were identified as the rates
of absorption and secretion, respectively.
We also investigated the effect of epinephrine on paracellular flux by
measuring the mucosal-to-serosal transport of
[3H]mannitol. The addition of 0.1 mM
epinephrine to the perfusate of the mucosal side did not induce an
increase in [3H]mannitol transport (control,
129.2 ± 7.4 nmol/g wet wt./30 min; epinephrine, 155.0 ± 7.2 nmol/g wet wt./30 min), indicating that the flow of this inert marker
was not substantially affected by epinephrine.
Effects of Various Adrenergic Agents on BP Transport in Rat Small
Intestine.
The effect of various adrenergic agonists and
antagonists were investigated to identify the adrenoceptor subtype that
mediates the stimulatory action of epinephrine on the
mucosal-to-serosal transport of BP in rat small intestine. The addition
of phenylephrine, clonidine, dobutamine, or salbutamol to the luminal
perfusate did not affect BP transport (Table 1). Isoproterenol
stimulated BP transport but to an extent lesser than that observed with
epinephrine. However, the addition of phenylephrine or clonidine
together with isoproterenol increased BP transport to the same extent
as that observed with epinephrine. The addition of phenylephrine in the presence of salbutamol, but not in the presence of dobutamine, also
increased of BP transport by the same extent as did epinephrine alone.
Tolazolin or propranolol inhibited the epinephrine-induced increase in
BP transport (Table 2). These results
thus indicate that the stimulatory effect of epinephrine on BP
transport is mediated by both
2-adrenoceptors
and either
1- or
2-adrenoceptors.
View this table:
[in this window]
[in a new window]
|
TABLE 2
Effects of adrenergic antagonists on epinephrine-induced BP transport
in rat small intestine
Rat small intestinal lumen that had been equilibrated with Ringer's
solution containing 1 mM BP and a trace amount of [3H]BP for
15 min were perfused for 30 min with the same solution in the absence
or presence of epinephrine and the indicated adrenergic antagonists.
The amount of BP in the serosal solution was then determined as
described in the text. Data are mean ± S.E. for four to eight
loops.
|
|
Effects of Dibutyryl cAMP, Forskolin, Staurosporine, and H-8 on BP
Transport in Rat Small Intestine.
The addition of 10 µM
dibutyryl cAMP or 2.5 µM forskolin to the luminal perfusate increased
BP transport but to a lesser extent than did epinephrine (Table
3). However, the addition of dibutyryl cAMP or forskolin in the presence of 0.1 mM phenylephrine or 0.1 mM
clonidine stimulated BP transport to an extent similar to that observed
with epinephrine. These results suggest that the contribution of
-adrenoceptors to the effect of epinephrine on BP transport is
mediated by an increase in the intracellular concentration of cAMP.
Indeed, this suggestion was supported by the observation that perfusion
of the loops with epinephrine or forskolin significantly increased the
cAMP content of the mucosal cells (Table
4). To evaluate whether the effect of
cAMP on BP transport is mediated by cyclic AMP-dependent protein kinase
(PKA), we treated intestinal lumen for 15 min with 1 µM staurosporine
or 60 µM H-8, both of which are inhibitors of this enzyme, before
perfusion with 0.1 mM epinephrine. Both staurosporine and H-8 abolished
the epinephrine-induced increase in BP transport in the continued
presence of them (Table 3), suggesting that the stimulatory effect of
cAMP is mediated by PKA.
View this table:
[in this window]
[in a new window]
|
TABLE 3
Effects of dibutyryl cAMP, forskolin, staurosporine, and H-8 on BP
transport in rat small intestine
After equilibration with Ringer's solution containing 1 mM BP and a
trace amount of [3H]BP, rat small intestinal lumen was
perfused for 30 min with the same solution containing the indicated
agents. For the staurosporine and H-8 experiments, loops were
pretreated with these inhibitors for 15 min before the addition of
epinephrine to the luminal perfusate. The amount of BP in the serosal
solution was then determined as described in the text. Data are
mean ± S.E. for four loops.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4
Effects of epinephrine and forskolin on cAMP content of rat small
intestinal mucosa
Rat small intestinal lumen was perfused for 30 min with or without
epinephrine or forskolin in the presence of 0.5 mM
isobutylmethylxanthine. Mucosa was then scraped from the intestinal
loops, rapidly frozen, and subsequently assayed for cAMP. Data are
mean ± S.E. for four loops.
|
|
Stereospecificity of BP Transport in Rat Small Intestine.
To
investigate the stereospecificity of the BP transport system in rat
small intestine, we investigated the effects of various compounds known
to be transported by PepT1. Glycyl-L-alanine, glycyl-L-leucine, glycylsarcosine, and
glycyl-glycyl-glycine were used as representative peptides. Cephalexin
and cefadroxil were as representative zwitterionic
-lactams, and
cephalothin was as a representative anionic
-lactam. After perfusion
of the lumen with Ringer's solution containing BP in the presence of
these compounds, epinephrine was added to the perfusate at a
concentration of 0.1 mM and perfusion was continued for an additional
30 min. Glycyl-L-alanine, glycyl-L-leucine,
glycylsarcosine, and glycyl-glycyl-glycine reduced the extent of
epinephrine-induced BP transport by 80 to 90% (Table
5). Cephalexin, cefadoroxil, and
cephalothin reduced epinephrine-induced BP transport by 50%, which is
consistent with previous data (Poschet et al., 1996
). These results
suggested that like peptides and zwitterionic or anionic
cephalosporins, BP is transported by PepT1 in rat small intestine.
View this table:
[in this window]
[in a new window]
|
TABLE 5
Effects of various peptides and cephalosporins on epinephrine-induced
BP transport in rat small intestine
After equilibration with Ringer's solution containing 1 mM BP and a
trace amount of [3H]BP, rat small intestinal lumen was
perfused for 15 min in the same solution with or without peptides or
zwitterionic or anionic cephalosporins. Perfusion was then continued
for 30 min in the presence or absence of epinephrine. The extent of BP
transport into the serosal solution was then determined as described in
the text. Data are mean ± S.E. for four loops.
|
|
Effects of Epinephrine and a Membrane H+ Gradient on
Uptake of BP into BBM and BLM Vesicles.
BBM vesicles prepared from
rat small intestine that had been perfused in the absence or presence
of 0.1 mM epinephrine for 60 min were suspended in buffer 3 and
incubated for various times at 25°C in buffer 3 containing 1 mM BP
and a trace amount of [3H]BP. The extent of BP
uptake into BBM vesicles prepared from epinephrine-perfused intestinal
loops was greater than that for vesicles prepared from control loops
(Fig. 3). The initial rate of BP uptake
into BBM vesicles has previously been shown to be markedly increased in
the presence of an H+ gradient (Poschet et al.,
1996
). To generate such a gradient, we suspended BBM vesicles in buffer
3 and then with buffer 3 in which Tris-HCl (pH 7.4) was replaced with
Mes-Tris (pH 6.0). The initial rate of BP uptake was markedly increased
in the presence of the H+ gradient, showing the
characteristic overshoot phenomenon (Fig. 3). In the presence or
absence of the H+ gradient, the extent of BP
uptake into BBM vesicles prepared from epinephrine-perfused intestinal
loops was greater than that for vesicles prepared from control loops at
all incubation times. The effect of the initial
H+ gradient on the extent of BP uptake was no
longer significant at 30 min. Even in the absence of driving gradient,
the equilibrium uptake at 30 min was larger in BBM vesicles prepared
from epinephrine-stimulated loops than that for vesicles from control
loops.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of the presence of a H+ gradient
on the time course of BP uptake by BBM vesicles prepared from rat small
intestine perfused in the absence or presence of epinephrine. BBM
vesicles were prepared from rat small intestinal lumen that had been
perfused for 60 min in the absence or presence of 0.1 mM epinephrine,
as indicated. Vesicles were suspended in buffer 3 and then incubated
for the indicated times at 25°C with 1 mM BP and a trace amount of
[3H]BP either in buffer 3 or in buffer 3 in which
Tris-HCl (pH 7.4) was replaced with Mes-Tris (pH 6.0). Uptake of BP was
then terminated and assayed as described in Experimental
Procedures. Data are mean ± S.E. for vesicles prepared
from three loops.
|
|
To estimate the kinetic of transport of BP in BBM vesicles prepared
from intestinal loops perfused with or without epinephrine, we measured
the extent of uptake of BP at various concentrations at 30 min. As
shown in Fig. 4, uptake of BP into both
the vesicles was evaluated kinetically by the Michaelis-Menten
equation. The values of the apparent
Km for the uptake of BP into BBM
vesicles prepared from intestinal loops perfused with and without
epinephrine were 0.24 ± 0.1 and 0.25 ± 0.2 mM, and the
Vmax values were 3.93 ± 0.4 and
1.82 ± 0.2 nmol/mg protein/30 min, respectively.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Concentration-response relation for BP uptake into
BBM vesicles from rat small intestine perfused in the absence or
presence of epinephrine. a, BBM vesicles were prepared from rat small
intestinal lumen that had been perfused for 60 min in the absence or
presence of 0.1 mM epinephrine, as indicated. Vesicles were suspended
in buffer 3 and then incubated for 30 min at 25°C with a trace amount
of [3H]BP in buffer 3. Uptake of BP was then
terminated and assayed as described in Experimental
Procedures. Data are mean ± S.E. for vesicles prepared
from three loops. b, Eadie-Hofstee plot (V versus
V/S), where V is the velocity of BP
transport (nmol/g wet wt./h). and S is BP concentration
(mM).
|
|
BLM vesicles prepared from rat small intestine that had been perfused
in the absence or presence of 0.1 mM epinephrine for 60 min were
suspended in buffer 2 and incubated either with buffer 2 or with buffer
2 in which Tris-HCl (pH 7.4) was replaced with Mes-Tris (pH 6.0). The
extent of BP uptake into BLM vesicles prepared from
epinephrine-perfused intestinal loops was greater than that for
vesicles prepared from control loops; this difference was apparent in
the presence or absence of an H+ gradient (Fig.
5). In contrast to the situation with BBM
vesicles, the presence of an H+ gradient had no
marked effect on BP uptake into BLM vesicles. Thus, treatment of rat
small intestine with epinephrine increased the extent of BP uptake into
BBM and BLM vesicles.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of the presence of a H+ gradient
on the time course of BP uptake by BLM vesicles prepared from rat small
intestine perfused in the absence or presence of epinephrine. BLM
vesicles were prepared from rat small intestinal loop that had been
perfused for 60 min in the absence or presence of 0.1 mM epinephrine,
as indicated. Vesicles were suspended in buffer 2 and then incubated
for the indicated times at 25°C with 1 mM BP and a trace amount of
[3H]BP either in buffer 2 or in buffer 2 in which
Tris-HCl (pH 7.4) was replaced with Mes-Tris (pH 6.0). Uptake of BP was
then terminated and assayed as described in Experimental
Procedures. Data are mean ± S.E. for vesicles prepared
from three loops.
|
|
Effect of a Membrane H+ Gradient on BP Transport in
Intestinal Loops.
To evaluate the role of an
H+ gradient in epinephrine-induced BP transport
in intestinal loops, we investigated the effect of FCCP, amiloride, and
ouabain. Perfusion with FCCP inhibited epinephrine-induced BP transport
by 60% at the concentration that collapses H+
gradients (Table 6). The addition of 1 mM
amiloride, an inhibitor of the
Na+/H+ exchanger, to the
perfusate abolished the BP transport by 90%. Similarly, ouabain, at
the concentration that inhibits
Na+,K+-ATPase activity,
reduced epinephrine-induced BP transport by 90%.
View this table:
[in this window]
[in a new window]
|
TABLE 6
Effects of FCCP, amiloride, and ouabain on epinephrine-induced BP
transport in rat small intestine
After equilibration with Ringer's solution containing 1 mM BP and a
trace amount of [3H]BP, rat small intestinal lumen was
perfused for 15 min in the same solution with or without FCCP,
amiloride, or ouabain at the indicated concentrations. Perfusion was
then continued for 30 min in the presence or absence of epinephrine.
The amount of BP in the serosal solution was then determined as
described in the text. Data are mean ± S.E. for four loops.
|
|
These results suggest that epinephrine-induced BP transport is
dependent on an H+ gradient generated by the
Na+/H+ exchanger and
Na+,K+-ATPase, which have
previously been proposed to be responsible for generation and
maintenance of a membrane H+ gradient intestinal
epithelial cells (Tomita et al., 1995
).
 |
Discussion |
The intestinal mucosa is extensively innervated by adrenergic
fibers, and high concentrations of norepinephrine can potentially be
achieved in the vicinity of the epithelial cells (Valet et al., 1993
).
2-Adrenoceptors have been detected in the
intestinal mucosa, and the interaction of adrenergic receptors and
their agonists augmented the net absorption of
Na+ and Cl
ions from the
intestinal lumen (Paris et al., 1990
; Hirdebrand and Brown, 1992
).
-Adrenoceptors are also present in the intestine, and their quantity
was markedly increased in BLM of mucosal cells of intestinal loops
perfused with epinephrine (Ishikawa et al., 1997
). It appears that
-
and
-adrenergic agonists or antagonists added into the luminal
perfusate of intestinal loops migrate along transcellular or
paracellular pathways and then either interact directly with the
respective adrenoceptors located in the BLM of epithelial cells or
affect these cells indirectly via the enteric nervous system.
Peptides are transported by PepT1 in a manner that is dependent on an
H+ gradient generated by the
Na+/H+ exchanger and
Na+,K+-ATPase (Ganapathy
and Leibach, 1985
). Zwitterionic
-lactams are also transported by
PepT1 in the intestine (Fei et al., 1994
). Although Daniel (1996)
pointed out the controversy as to whether anionic
-lactams such as
BP are transported by the same transporter as that responsible for the
transport of zwitterionic
-lactams, it was recently demonstrated
that zwitterionic and anionic
-lactams do indeed share the same
transporter (Poschet et al., 1996
). In this study, the
epinephrine-induced increase in BP transport in rat small intestine was
reduced in the presence of peptides or of zwitterionic or anionic
-lactams, suggesting that these compounds are all transported by a
common transporter.
The uptake of BP across the BBM into enterocytes of the small intestine
was previously shown to occur in a saturable manner and to be
stimulated by an inwardly directed H+ gradient
(Kramer et al., 1990
). We have now shown that the treatment of rat
small intestine with FCCP at the concentration that sufficient to
collapse the H+ gradient inhibited
epinephrine-induced BP transport by 60%, suggesting that the membrane
H+ gradient in this loop is also important for
this effect of epinephrine. The
Na+/H+ exchanger located in
the BBM, together with
Na+,K+-ATPase in the BLM,
has been proposed to be responsible for the generation and maintenance
of such an H+ gradient (Ganapathy and Leibach,
1985
). The Na+/H+ exchanger
has also been detected in the BLM in rabbit ileum (Sundaram et al.,
1991
). In this study, treatment of rat small intestine with amiloride,
at a concentration that inhibits the
Na+/H+ exchanger, or with
ouabain, at a concentration that inhibits Na+,K+-ATPase, also
inhibited epinephrine-induced BP transport by 90%. These observations
demonstrate the importance of the
Na+/H+ exchanger and
Na+,K+-ATPase in
epinephrine-induced BP transport in rat small intestine. The
stimulation of
1- and
2-adrenoceptors induces activation of the
Na+/H+ exchanger rat
proximal nephrons (Liu et al., 1997
), although
2-adrenoceptor stimulation inhibits the
Na+/H+ exchanger activity
in renal BBM as a result of binding of the Na+/H+ exchanger regulatory
factor to the COOH-terminal tail of these receptors (Hall et al.,
1998
). Na+,K+-ATPase is
also activated by either
1- or
2-adrenergic agonists via an activation of a
calcium calmodulin-dependent protein phosphatase in renal tubule cells
(Aperia et al., 1992
). It is therefore likely that epinephrine induces
the generation and maintenance of an H+ gradient
across the BBM by interacting with either
1-
or
2-adrenoceptors and thereby activating the
Na+/H+ exchanger and
Na+,K+-ATPase.
The activity of PepT1 in human intestinal Caco-2 cells is increased by
incubation of cells with the dipeptide glycyl-glycine for 21 days; the
amounts of PepT1 protein and mRNA are also increased by this treatment
(Walker et al., 1998
). However, in our experiments, the
epinephrine-induced increase in the extent of BP transport is not
likely to be mediated by an increase in the abundance of PepT1 mRNA
because of the short incubation time (30 min). Several types of
transporters and channels traffic between the plasma membrane and
intracellular membranes in response to hormones or other agents. Such
trafficking is thought to be mediated by the exocytotic insertion of
vesicles containing transporters or channels into the plasma membrane
and by the endocytotic retrieval of these proteins (Bradbury and
Bridges, 1994
). Stimulation of
-adrenoceptors or vasopressin
receptors with respective agonists induces the activation of PKA and
either the translocation of SGLT1 to the BBM in rat intestine (Ishikawa
et al., 1997
) or the translocation of aquaporin-2 to the apical
membrane in rat kidney (Nielsen et al., 1993
), respectively. Recently,
PepT1 was shown to be translocated to the apical membrane from a
cytoplasmic pool in human intestinal cell monolayer by insulin
(Thamotharan et al., 1999
). In this study, BP uptake into BBM vesicles
prepared from epinephrine-perfused intestinal loops was greater than
that into those prepared from control loops, in either the presence or
absence of an H+ gradient. Even in the absence of
an H+ gradient, the
Vmax value for the uptake of BP into
BBM vesicles prepared from intestinal loops perfused with epinephrine
was twice that for BP uptake into control vesicles. These observations
suggest that epinephrine induces the activation of PKA in rat small
intestine and thereby promotes the trafficking of PepT1 to the BBM.
In conclusion, our data suggest that epinephrine acts at either
1- or
2-adrenoceptors
on rat intestinal epithelial cells to generate and maintain an
H+ gradient across the BBM and simultaneously
acts at
2-adrenoceptors to increase the amount
of PepT1 in the BBM. As a result of these interactions with its
receptors, epinephrine increases BP transport in the rat small intestine.
Accepted for publication November 22, 1999.
Received for publication August 10, 1999.
BBM, brush border membrane;
BP, benzylpenicillin;
BLM, basolateral membrane;
FCCP, carbonyl cyanide
p-trifluoromethoxy phenylhydrazone;
H-8, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide
dihydrochloride;
PKA, cyclic AMP-dependent protein kinase;
Mes, 2-(N-morpholino)ethanesulfonic acid.